222 related articles for article (PubMed ID: 37966393)
1. Effects of sirtuin 1 deficiency on trophoblasts and its implications in the pathogenesis of pre-eclampsia.
Yu H; Chen L; Du P; Liu X; Xia Y
J Obstet Gynaecol; 2023 Dec; 43(2):2282103. PubMed ID: 37966393
[TBL] [Abstract][Full Text] [Related]
2. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
3. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
Xiang QQ; Yang Z; Huai J; Wang GJ
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
[No Abstract] [Full Text] [Related]
4. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
5. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
[TBL] [Abstract][Full Text] [Related]
6. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
8. Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
Li J; Cai A; Yuan Q; Ding H; Zhao D
Int J Gynaecol Obstet; 2019 May; 145(2):176-181. PubMed ID: 30801711
[TBL] [Abstract][Full Text] [Related]
9. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
12. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
[TBL] [Abstract][Full Text] [Related]
14. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
Tang P; Xu J; Xie BJ; Wang QM
Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of miR-299 suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting HDAC2 in pre-eclampsia.
Gao Y; She R; Wang Q; Li Y; Zhang H
Biomed Pharmacother; 2018 Jan; 97():1222-1228. PubMed ID: 29145147
[TBL] [Abstract][Full Text] [Related]
16. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510
[TBL] [Abstract][Full Text] [Related]
17. Trimethylamine N-Oxide increases soluble fms-like tyrosine Kinase-1 in human placenta via NADPH oxidase dependent ROS accumulation.
Chang QX; Chen X; Ming-Xin Yang ; Zang NL; Li LQ; Zhong N; Xia LX; Huang QT; Zhong M
Placenta; 2021 Jan; 103():134-140. PubMed ID: 33120049
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
19. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
[TBL] [Abstract][Full Text] [Related]
20. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
